Publication Delays Impact Careers of Early-Career Researchers

By João L. Carapinha

May 19, 2025

The article “Dear editors, your publication delays are damaging our careers” by Chia-Hsuan Hsu highlights how publication delays hurt careers, especially for early-career researchers. With publication records key for jobs and tenure, slow editorial processes stall academic progress. The author shares waiting 18 months for a decision, blaming poor reviewer recruitment. This calls on editors to improve efficiency.

The Detrimental Impact of Delays

The article notes that publication delays impact careers by harming early-career researchers. Delays can cost job and funding chances, hindering growth. East Asia heavily weighs publication history in evaluations, making delays more damaging than in regions valuing broader contributions. Bottlenecks often stem from poor reviewer recruitment and communication, not scientific merit. While preprints speed up sharing findings, they often don’t count for career evaluations in Japan and Taiwan.

The article reflects broader issues in publishing and evaluation. The global academic system overvalues publications for hiring and funding, pressuring early-career researchers into a publish or perish culture. A few big publishers control the market while unpaid editorial labor leads to slow, profit-driven processes that clash with researchers’ needs. Delays often arise from reviewer shortages and overworked editors, hurting researchers needing timely output.

Proactive Solutions for a Changing Landscape

  • Reforming Academic Evaluation: Reports suggest valuing preprints and datasets more, but until reforms spread, early-career researchers suffer.
  • Innovative Peer Review Models: Open peer review and reviewer incentives could help, needing publisher and institutional cooperation.
  • Policy Recommendations: Health agencies and consortia could recognize preprints in evaluations, easing delays’ harm.

In summary, the article shows how publication delays hurt careers. Fixing this needs changes from editors, publishers, and institutions to ensure fair opportunities. For deeper insights, explore the source material.

Reference url

Recent Posts

Health Investment Returns: Harnessing Health as a Strategic Economic Asset

By João L. Carapinha

November 18, 2025

Health as a Strategic Economic Imperative A country's enduring strength stems not solely from military or industrial resources but from the vitality and productivity of its populace. A recent EFPIA Guest Blog by Michael Oberreiter frames he...
Emblaveo MDR Infections: Evaluating a New Solution for Multidrug-Resistant Gram-Negative Infections
Emblaveo Approved for MDR Gram-Negative Infections Emblaveo MDR infections pose a growing threat in Portugal, with the public assessment report evaluating Emblaveo (aztreonam + avibactam) for financing under Decree-Law No. 97/2015....
Promising Advances in TNBC Treatment: Sacituzumab Govitecan in First-Line Therapy

By HEOR Staff Writer

November 17, 2025

Sacituzumab Govitecan Shows Promise in First-Line TNBC Therapy Sacituzumab govitecan for TNBC represents a major step forward in treating untreated